Question special

Congratulations to the authors on the interesting work.
It appears that the 21-gene expression assay is broadly indicated for estrogen-receptor-positive patients. Could the 21-gene test also be used to find prognostic information for estrogen-receptor-positive, HER2 positive patients? In other words, is there a specific rationale in studying HER2 negative patients only?